BRIEF-RepliCel therapy for pattern baldness proceeds to clinical trial launch in Japan

Thu Jul 21, 2016 8:20am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 21 (Reuters) - RepliCel Life Sciences Inc :

* RCH-01 product cleared by Japanese regulatory authorities for use in clinical research study launching now in Japan

* Study financed by Shiseido company, each product being injected to be manufactured by Shiseido at facility in Kobe, Japan

* Replicel's cell therapy for pattern baldness proceeds to clinical trial launch in Japan Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)